Inspire Medical Systems INSP Cash Flow Statement (2017-2026)

NYSE INSP
$71.26 +0.21 (+0.30%)
As of: Oct 22, 2026 · 9:45 AM EDT
Reported Financials

Inspire Medical Systems Quarterly Cash Flow Statement

Periods 38 quarters
Latest Jun 2026

Inspire Medical Systems reported cash from operations of $23.23M and free cash flow of $14.07M for the quarter ended Jun 2026, up 765.4% year over year. This cash flow statement covers 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-10.35M-2.39M-16.69M-14.49M-16.85M3.15M-15.42M-11.95M-8.54M14.76M-10.01M9.79M18.50M35.22M2.99M-3.59M9.93M136.09M-11.29M0.31M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.06M0.06M0.06M
Depreciation & Amortization (CF)Dep. & Amort.
0.34M0.34M0.36M0.42M0.51M0.57M0.59M0.66M0.78M0.82M0.84M1.38M1.85M2.48M3.04M3.41M3.68M3.82M5.11M4.60M
Share-based CompensationStock Comp.
6.81M7.03M9.72M12.66M14.59M15.03M18.23M21.57M19.83M22.88M26.32M32.30M28.20M29.11M31.10M41.70M29.50M28.05M30.70M31.20M
Deferred Taxes
1.01M10.15M
Asset Writedowns and ImpairmentWritedown
4.00M
Other non-cash itemsOther Non-Cash
0.36M0.39M0.40M0.33M-0.27M0.42M0.36M0.42M0.48M0.87M0.52M0.14M0.44M0.41M0.51M0.87M0.19M0.54M0.55M0.19M
Change in Working Capital
Change in ReceivablesChange Receivables
1.87M7.50M0.38M5.83M8.19M12.62M-1.49M4.61M8.47M18.63M-18.96M7.72M9.90M3.95M-0.26M44.58M-29.72M11.63M-14.29M-1.93M
Change in InventoryChange Inventory
2.28M1.66M4.97M-0.34M-6.71M-3.26M3.78M5.18M5.27M7.77M15.09M10.05M8.41M12.69M19.61M21.91M20.14M3.52M20.94M4.22M
Change in Account PayablesChange Payables
1.30M1.29M5.52M-1.77M4.85M5.75M8.39M3.39M-0.71M-1.78M3.56M-8.56M1.65M3.96M-9.52M21.33M6.54M-22.10M7.13M-13.83M
Change in Accured ExpensesChange Accured Exp.
4.95M2.83M-6.92M4.51M9.44M4.91M-10.62M3.12M4.31M10.09M-12.40M3.72M7.89M13.66M-16.32M5.01M10.80M6.63M-12.32M-3.91M
Change in Other Operating AssetsOther Assets Change
-0.40M-0.39M-0.22M2.13M-0.21M1.10M0.58M3.21M-0.84M1.81M-0.01M18.93M-14.45M-2.12M-1.77M2.41M1.47M-3.76M1.26M2.81M
Other Working Capital ChangesOther WC Changes
0.40M0.39M0.22M-2.13M0.21M-1.10M-0.58M-3.21M0.84M-1.81M0.01M-18.93M14.45M2.12M1.77M-2.41M-1.47M3.76M-1.26M-2.81M
Cash from OperationsCash from Ops.
-0.34M0.73M-12.75M-5.95M11.00M19.27M-1.34M5.09M3.64M17.27M8.86M-0.08M52.28M69.18M-6.70M2.68M68.53M52.47M12.85M23.23M
Investing Activities
Capital ExpendituresCapex
1.15M0.53M1.22M1.42M3.51M2.95M3.75M4.86M6.99M8.03M11.70M12.39M8.01M7.03M8.41M9.00M10.44M10.66M9.73M9.16M
Change in Property, Plant and EquipmentChange in PP&E
-1.15M-0.53M-1.22M-1.42M-3.51M-2.95M-3.75M-4.86M-6.99M-8.03M-11.70M-12.39M-8.01M-7.03M-8.41M-9.00M-10.44M-10.66M-9.73M-9.16M
Purchase of InvestmentsInvestments Purchased
0.25M10.00M0.25M0.25M137.25M143.94M55.74M56.30M225.51M81.06M17.92M95.84M73.74M62.94M57.31M24.93M
Sale and Maturity of InvestmentsInvestments Sold
31.30M10.00M0.25M47.90M74.31M130.54M91.85M24.17M149.48M75.05M61.68M55.79M37.64M
Cash from Investing ActivitiesCash from Investing
30.15M-0.53M-1.47M-11.42M-3.76M-2.95M-3.75M4.90M-144.24M-151.72M-19.54M5.62M-102.97M3.76M-1.55M46.56M-11.65M-11.92M-11.25M3.55M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
21.44M
Non-Current Debt
-21.44M
Net Debt Issuances and RepaymentsNet Debt Issuance
-21.44M
Change in Capital Stock
Common Stock IssuedStock Issued
3.84M4.08M3.09M3.68M245.56M7.29M7.38M15.91M4.02M3.81M3.62M8.95M14.23M0.98M6.44M5.43M0.35M2.40M0.11M2.60M
Shares Repurchased
75.01M50.00M50.01M
Net Shares Issued and RepurchasedNet Shares Issued
3.84M4.08M3.09M3.68M245.56M7.29M7.38M15.91M4.02M3.81M3.62M8.95M14.23M0.98M-68.57M5.43M-49.65M-47.61M0.11M2.60M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
3.84M4.08M3.09M3.68M245.56M7.29M7.38M15.91M4.02M3.81M3.62M8.95M14.23M0.98M-68.57M5.43M-49.65M-47.61M0.11M2.60M
Other financing activitiesOther financing
-0.04M-1.75M-0.97M-0.52M-13.93M-2.85M-1.86M-4.34M3.88M-19.19M-1.73M-1.43M-0.69M-7.59M-0.69M
Cash from Financing ActivitiesCash from Financing
3.84M4.08M3.04M0.62M224.13M7.29M5.63M14.93M3.50M-10.12M0.77M7.09M9.89M-70.14M-87.76M3.70M-51.08M-48.31M-7.48M1.91M
Additional items
Exchange Rate EffectFX Effect
0.01M-0.01M-0.01M0.03M-0.13M0.18M0.01M0.00M-0.05M0.21M-0.21M-0.01M0.27M-0.17M-0.25M0.10M0.12M-0.28M0.00M0.14M
Change in Cash
33.66M4.27M-11.18M-16.72M231.24M23.78M0.54M24.92M-137.15M-144.36M-10.12M12.62M-40.52M2.64M-96.27M53.05M5.92M-8.03M-5.88M28.83M
Ending Cash Balance
210.20M214.47M203.29M186.57M417.81M441.59M442.13M467.05M329.90M185.54M175.42M188.04M147.51M150.15M53.88M106.93M112.85M104.81M98.93M127.76M
Free Cash FlowFCF
-1.49M0.20M-13.96M-7.37M7.49M16.32M-5.10M0.24M-3.35M9.23M-2.84M-12.47M44.28M62.15M-15.11M-6.31M58.09M41.81M3.12M14.07M
Net Cash FlowNCF
33.65M4.28M-11.17M-16.75M231.37M23.61M0.53M24.92M-137.10M-144.57M-9.91M12.63M-40.80M2.80M-96.02M52.94M5.80M-7.76M-5.88M28.69M
Interest Paid
0.48M0.47M0.47M0.46M1.40M0.02M0.00M0.01M0.12M0.02M

Inspire Medical Systems Cash Flow Statement API

Pull Inspire Medical Systems's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=INSP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY